Calgb/Swog 80405: Phase III Trial of Irinotecan/5-Fu/Leucovorin (Folfiri) or Oxaliplatin/5-Fu/Leucovorin (Mfolfox6) with Bevacizumab (Bv) or Cetuximab (Cet) for Patients (Pts) with Expanded Ras Analyses Untreated Metastatic Adenocarcinoma of the Colon Or Rectum (Mcrc)
Heinz‐Josef Lenz,Donna Niedzwiecki,Federico Innocenti,Charles D. Blanke,M.R. Mahony,Bert H. O’Neil,James E. Shaw,Blasé N. Polite,Howard S. Höchster,J. Atkins,Richard M. Goldberg,Robert J. Mayer,Richard L. Schilsky,Monica M. Bertagnolli,Alan P. Venook